NTLA
$11.42+0.71%
Intellia Therapeutics Inc.Stock · HealthcareRussell 2000 0.07%Nasdaq Composite 0.005%US Stock Market 0.003%Russell 3000 0.003%
Intellia Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Intellia Therapeutics Inc. total returns by year (2017–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $8.99 | $11.42 | 0.0% | +27.0% | |
| 2025 | $11.66 | $8.99 | 0.0% | -22.9% | |
| 2024 | $30.49 | $11.66 | 0.0% | -61.8% | |
| 2023 | $34.89 | $30.49 | 0.0% | -12.6% | |
| 2022 | $118.24 | $34.89 | 0.0% | -70.5% | |
| 2021 | $54.40 | $118.24 | 0.0% | +117.4% | |
| 2020 | $14.67 | $54.40 | 0.0% | +270.8% | |
| 2019 | $13.65 | $14.67 | 0.0% | +7.5% | |
| 2018 | $19.22 | $13.65 | 0.0% | -29.0% | |
| 2017 | $13.11 | $19.22 | 0.0% | +46.6% |
- Annualized
- -8.8%
- 2017–2026
- Average year
- +27.3%
- 9 full years
- Best year
- +270.8%
- 2020
- Worst year
- -70.5%
- 2022
- Positive years
- 4/9
- 44% up
Annualized (CAGR)
-8.8%
2017–2026
Average year
+27.3%
9 full years
Best year
+270.8%
2020
Worst year
-70.5%
2022
Positive years
4/9
44% up
Total return by period#
Annual
-200%-100%0%100%200%
2017+47%'17
2018-29%'18
2019+7.5%'19
2020+271%'20
2021+117%'21
2022-70%'22
2023-13%'23
2024-62%'24
2025-23%'25
2026+27%'26
Methodology#
Total returns, dividends reinvested, measured on NTLA. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Intellia Therapeutics Inc.'s average annual return?
- Since 2017, Intellia Therapeutics Inc. (NTLA) has returned about -8.8% a year (the compound annual growth rate) and an average calendar-year return of 27.3%.
- What were Intellia Therapeutics Inc.'s best and worst years?
- Over 2017–2026, the best year was 2020 (+270.8%) and the worst was 2022 (-70.5%).
- How often is Intellia Therapeutics Inc. up in a year?
- 4 of the 9 full years since 2017 were positive — about 44% of the time.
More on Intellia Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100